SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Glycotope Received Regulatory Approval for Glycooptimized and Fully Human Glycosylated Antibody CetuGEX(TM) and Enrolls First Patients in Clinical Trial